Mori K - Search Results

1

[Multidisciplinary treatment of advanced invasive thymoma].

Yokoi K, Miyazawa N, Mori K, Saito Y, Tominaga K, Matsui M, Kitagawa T. Yokoi K, et al. Among authors: mori k. Kyobu Geka. 1993 Jan;46(1):26-30. Kyobu Geka. 1993. PMID: 8418355 Japanese.

2

Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesis.

Mori K, Saito Y, Tominaga K. Mori K, et al. Am J Clin Oncol. 1993 Aug;16(4):338-41. doi: 10.1097/00000421-199308000-00013. Am J Clin Oncol. 1993. PMID: 8392288 Clinical Trial.

3

[A case of invasive thymoma displaying endobronchial polypoid growth].

Yokoi K, Miyazawa N, Mori K, Saito Y, Tominaga K, Suzuki K. Yokoi K, et al. Among authors: mori k. Nihon Kyobu Shikkan Gakkai Zasshi. 1990 Mar;28(3):529-34. Nihon Kyobu Shikkan Gakkai Zasshi. 1990. PMID: 2214396 Review. Japanese.

4

Tumor lysis syndrome in invasive thymoma with peripheral blood T-cell lymphocytosis.

Yokoi K, Miyazawa N, Kano Y, Akutsu M, Mori K, Tominaga K, Imura G. Yokoi K, et al. Among authors: mori k. Am J Clin Oncol. 1997 Feb;20(1):86-9. doi: 10.1097/00000421-199702000-00020. Am J Clin Oncol. 1997. PMID: 9020297

5

Phase II study of cisplatin as a 5-day continuous infusion with vindesine plus recombinant human granulocyte-colony-stimulating factor in the treatment of advanced non-small-cell lung cancer.

Saito Y, Mori K, Tominaga K, Yokoi K, Miyazawa N. Saito Y, et al. Among authors: mori k. Cancer Chemother Pharmacol. 1992;31(2):81-4. doi: 10.1007/BF00685091. Cancer Chemother Pharmacol. 1992. PMID: 1280537 Clinical Trial.

6

Phase II study of cisplatin continuous infusion plus vindesine in the treatment of non-small-cell lung cancer.

Mori K, Saito Y, Tominaga K. Mori K, et al. Am J Clin Oncol. 1992 Aug;15(4):344-7. doi: 10.1097/00000421-199208000-00015. Am J Clin Oncol. 1992. PMID: 1325109 Clinical Trial.

7

Invasive thymoma with intracaval growth into the right atrium.

Yokoi K, Miyazawa N, Mori K, Saito Y, Tominaga K, Imura G, Shimamura K, Hirotani T, Kiso I. Yokoi K, et al. Among authors: mori k. Ann Thorac Surg. 1992 Mar;53(3):507-9. doi: 10.1016/0003-4975(92)90281-8. Ann Thorac Surg. 1992. PMID: 1540072

8

Phase II study of 5-day continuous infusion of cis-diamminedichloroplatinum(II) in the treatment of non-small-cell lung cancer.

Saito Y, Mori K, Tominaga K, Yokoi K, Miyazawa N. Saito Y, et al. Among authors: mori k. Cancer Chemother Pharmacol. 1990;26(6):389-92. doi: 10.1007/BF02994086. Cancer Chemother Pharmacol. 1990. PMID: 2171793 Clinical Trial.

9

A phase II study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer.

Mori K, Machida S, Yoshida T, Yoshida M, Kano Y, Tominaga K. Mori K, et al. Cancer Chemother Pharmacol. 1999;43(6):467-70. doi: 10.1007/s002800050925. Cancer Chemother Pharmacol. 1999. PMID: 10321506 Clinical Trial.

10

[Effective combination chemotherapy using paclitaxel in the treatment of a small-cell lung cancer patient resistant to multiple drugs].

Yoshida T, Mori K, Kamiyama Y, Tominaga K. Yoshida T, et al. Among authors: mori k. Gan To Kagaku Ryoho. 2001 Oct;28(10):1437-40. Gan To Kagaku Ryoho. 2001. PMID: 11681253 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,620 results

Search Page

Filters